BCLI - BRAINSTORM CELL THERAPEUTICS INC.
1.18
-0.040 -3.390%
Share volume: 117,801
Last Updated: 05-09-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$1.22
-0.04
-0.03%
Summary score
23%
Profitability
25%
Dept financing
42%
Liquidity
32%
Performance
15%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-111.06%
Return on assets
-35.37%
Return on sales
0%
Return on invested capital
111.12%
Total debt ratio
71.93%
Debt ratio change over timeo
0%
Current Ratio
3.55%
Quick Ratio
0%
Cash Position Ratio
1.19%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-29.92%
Return on assets
-53.88%
Return on sales
0%
Return on invested capital
108.07%
Total debt ratio
101.66%
Debt ratio change over timeo
0%
Current Ratio
2.16%
Quick Ratio
0%
Cash Position Ratio
1.69%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
-17.28%
Return on assets
-13.72%
Return on sales
0%
Return on invested capital
110.13%
Total debt ratio
20.53%
Debt ratio change over time
0%
Current Ratio
4.72%
Quick Ratio
0%
Cash Position Ratio
3.85%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | BCLI | AMGN | GILD | BNTX |
|---|---|---|---|---|
| Return on equity | -111.06% | 12.3% | 4.66% | -13.17% |
| Return on assets | -35.37% | 3.6% | 3.82% | -8.16% |
| Return on sales | 0% | 41.82% | 38.61% | -204.65% |
| Return on invested capital | 111.12% | 7.81% | 4.85% | -53.4% |
| Profitability | 25% | 75% | 59% | 0% |
| Total debt ratio | 71.93% | 75.51% | 65.79% | 38.48% |
| Debt ratio change over time | 0% | 0% | 341.77% | 0% |
| Dept financing | 24% | 25% | 47% | 13% |
| Current Ratio | 2.16% | 1.87% | 2.93% | 3.17% |
| Quick Ratio | 0% | 1.53% | 2.83% | 3.11% |
| Cash Position Ratio | 1.69% | 0.73% | 2.29% | 2.96% |
| Liquididy | 35% | 55% | 63% | 72% |
| Short-term ratios | BCLI | AMGN | GILD | BNTX |
|---|---|---|---|---|
| Return on equity | -29.92% | 18.05% | 0.63% | -13.17% |
| Return on assets | -53.88% | 3.58% | 3.44% | -8.16% |
| Return on sales | 0% | 36.22% | 35.02% | -204.65% |
| Return on invested capital | 108.07% | 5.97% | 1.16% | -53.4% |
| Profitability | 25% | 76% | 49% | 0% |
| Total debt ratio | 101.66% | 83.77% | 66.41% | 38.48% |
| Debt ratio change over time | 0% | 0% | -1.12% | 0% |
| Dept financing | 50% | 21% | 16% | 9% |
| Current Ratio | 2.16% | 1.87% | 2.93% | 3.17% |
| Quick Ratio | 0% | 1.53% | 2.83% | 3.11% |
| Cash Position Ratio | 1.69% | 0.73% | 2.29% | 2.96% |
| Liquididy | 31% | 33% | 65% | 75% |
